Sanofi Aventis receives no from Genzyme for first offer

Forbes shares that the first attempt for Sanofi Aventis, a bid of $18.5 billion, was rejected by Genzyme. Genzyme believes that the company should be valued at a much higher price. The bid from Sanofi Aventis has been expected. Genzyme is facing a few manufacturing issues when inspectors found particles of trash and other particles in the medication manufactured at several plants. Stock prices of Genzyme, however, continue to rise today, showing that investors believe that Sanofi Aventis will come back with a higher bid.

Share this article with your social network, just click below to share now!

Share |

Sanofi Aventis eyeing Genzyme

Reports Friday surfaced that Sanofi Aventis is looking to acquire Genzyme as it faces stiff competition from generic drugs. By acquiring Genzyme, it would be their first step into the generics and biosimilars market.

According to the article:
[Genzyme's] research pipeline includes candidates for genetic diseases like Duchenne and Becker muscular dystrophy, Niemann-Pick type B, and Parkinson disease. It also has drugs in development for cardiometabolic, renal, transplant, and immune diseases, as well as hematologic oncology.

Source: Genetic Engineering & Biotechnology News

Share this article with your social network, just click below to share now!

Share |

2010 DDP Awards: Partnering Excellence Nominee: Genzyme

Genzyme Pharmaceuticals has built several strong strategic relationships with companies such as SurModics Pharmaceuticals and Pharmidex Pharmaceuticals in the area of drug delivery. The collaborations span functional areas from business development to science to marketing and draw upon available strengths and resources in an innovative way. This year for example, Genzyme Pharmaceuticals and SurModics Pharmaceuticals hosted an educational webinar on the collaborative service technology Design for Peptide DeliverySM (www.d4pd.com) with scientists from each company speaking on the scientific background and benefit of the service. The processes of communication and follow up within the strategic relationships are exemplary examples of how collaborations do work to create more value and business for both parties in the long term.

The winners will be announced at an awards ceremony on Tuesday, January 26 at the Drug Delivery Partnerships International Conference.

Share this article with your social network, just click below to share now!

Share |

Join over 250 Biopharmaceutical Executives who will experience DDP in less than 3 weeks

Will you GAIN INSIGHTS from the top renowned thought leaders on leveraging drug delivery to maximize value?

*Merck Serono * Pfizer * Purdue Pharma * BMS * Bayer * Novartis * Ranbaxy Labs * GSK * Amgen * Genzyme * Mannkind Corporation * Eurand * Sandoz * Healthcare Futurists * Deutsche Bank * and 80 + more…

Will you EXPLORE in-person the latest cutting-edge drug delivery technologies and mechanisms?

*Nanotechnology * RNAi Delivery * Modified Release * Biosimilars * NanoCrystals * Laser Epidermals * Electronic Injection Devices * Pain Product Delivery * Antibodies * Transdermal Systems * Orals * Needle-free vs. Needle-Based Systems

Will you OBTAIN the newest industry strategies and information through top-level keynotes, case studies and panel discussions addressing what you need to know NOW?

*Pipelines * Partnerships * Patients * Policy * Profitability * Emerging Markets * Reform * Technology

Will you NETWORK with the world’s leading Pharma, Biotech and Drug Delivery companies?

3M Company * AAIPharma Services Corporation * Abbott Laboratories * Abraxis BioScience Inc * Ache Laboratorios Farmaceuticos * Adhesives Research Inc * Aisling Capital * Alkermes Inc * Allergan Inc * Altea Therapeutics * Amgen Inc * Amylin Pharmaceuticals Inc * Anchen Pharmaceuticals Inc * Antares Pharma * Aprecia Pharmaceuticals Company * Aradigm Corporation * Arch Life Sciences * Arecor Limited * Astellas Pharma * Atlantic Pharmaceuticals Inc * Aveva Drug Delivery Systems Inc * Bang & Olufsen Medicom AS * Banner Pharmacaps Inc * Baxter Healthcare Corporation * Bayer HealthCare * BD Horizons * BIND Biosciences Inc * Biogen Idec * Bioject Medical Technologies Inc * Bionumbers * Biotechnology Value Fund LP * Boston BioCom LLC * Bouty * Bristol Myers Squibb Company * Cambrex Corporation * Cambridge Consultants * Cambridge Consultants Inc * Camurus AB * CEDRA Corporation * Center for Health Value Innovation * Center for Medicine in Public Interest * ChemImage Corporation * Chiesi Farmaceutici SpA * Cigna * CIMA LABS * ComPan * CustomRx * Cydex Inc * Daniela Mavor * Davidson, Davidson & Kapple LLC * Depomed Inc * Deutsche Bank * Dharma Therapeutics * Dicerna Pharmaceuticals * Dow Corning Corporation * DPT Laboratories * DSM Biomedical * DSM Pharmaceutical Products Inc * Durect Corporation * EGEN Inc * ELAN Drug Delivery Incorporated * Elan Drug Technologies * Elcam Medical * Eli Lilly & Company * Emergent Technologies, Inc. * Endo Pharmaceuticals Inc * Eurand Inc * Flamel Technologies Inc * Flextronics * FMC Corporation * Future of Healthcare & the Changing Business Environment * Genentech Inc * Genzyme Corporation * Gerresheimer AG * GlaxoSmithKline Pharmaceuticals * Glide Pharma * Growthworks Capital Inc * H2A Associates * Halozyme Therapeutics Inc * Hannaford Brothers & Company * Haselmeier * Helvoet Pharma Inc * Henkel * Hospira Inc * INNERCAP Technologies Inc * Institut Rosell Inc * Insulet Corporation *
J S New * Janisys * Johnson & Johnson * Joyce Lonergan * KAI Pharmaceuticals Inc * Keystone Nano Inc * Labtec Gmbh * Landec Corporation * Lipocine Inc * Liquidia Technologies Inc * Losan Pharma GmbH * LTS Lohmann Therapy SystemsMadeira Therapeutics * MannKind Corporation *MAP Pharmaceuticals Inc * MedPhysion * MedTRACK * Merck & Company * Merck Serono SA * Merrion Pharmaceuticals * Mikron * Miller Tabak Co LLC * MIT * Mochida Seiyaku KK * MonoSol Rx * NexBio * Nissen Consulting Group, LLC * Northern Lipids Inc * Novartis * Noven Therapeutics LLC * Novo Nordisk * Oakwood Laboratories * Ocelus * Ompi of America * Orexo AB * Pacific Research * Palyon Corporation * Pantec Biosolutions AG * Pappas Ventures * Par Pharmaceutical Inc * Partners in Care * Partners Rx * Perfecseal * Pfeiffer & Valois Pharma * Pfizer Inc * Pharma Nueva Company Ltd * Pharmaceutics International Inc * PharmaCircle * Plantex USA Inc * PM360 * Prasco * Purdue Pharma LP * QPS LLC * Ranbaxy Labs Ltd * Ratio Inc * Receptor Therapeutics Inc * Regence Group * RXi Pharmaceuticals * Sandoz International GmbH * Sanofi Aventis Inc * SciDose LLC * Sofgen Pharmaceuticals * SR One * Supernus Pharmaceuticals Inc * SurModics Pharmaceuticals * SwissMedDev * Tablets & Capsules Inhalation Transdermal * Team Consulting Ltd * Technology Catalysts International * The Benfield Group * The Medical Pipeline * TransPharma Medical * Tris Pharma Inc * Unigene Laboratories Inc * Univ of California San Francisco * University of Connecticut * University of Illinois * University of Maryland * Unomedical AS * Upsher Smith Labs * URL Pharma * US FDA CDER * Valeo Partners * Vapotherm Inc * Vetter Pharma * Watson Pharmaceuticals * West Coast Clinical Trials LLC * Wildwood Ventures Ltd * Wyeth Research * Zogenix * Zosano Pharma

Will you MAKE your next deal?

As the leading drug delivery meeting place getting you closer to the next deal, Drug Delivery Partnerships is the one annual stop where you will experience the newest ideas, technologies and solutions for your business and pipeline needs. Can you get all of THAT in your office?

Register today to join the longest running and most respected drug delivery conference in the pharmaceutical industry.

The DDP exhibit hall is almost SOLD OUT! Only One Booth is Left! If this year’s attendance is any indicator, 2010 is going to be huge year for Drug Delivery. With over 80% pharmaceutical and biotech executives in attendance , we are outpacing 2009 and 2008. This is the ONE partnering event you can’t miss this year!

Register before January 8th and save $300 to maximize your event value and experience by making your key meetings and contacts now!

We look forward to seeing you in Orlando!

Share this article with your social network, just click below to share now!

Share |